YABLONKA URI (EVP and Chief Business Officer) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/29/2026ACC: 0001104659-26-068338
DirectorOfficer· EVP and Chief Business Officer
Since Nov 2018
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
219.1%
2/26/2026
68.46K→218.46K
Total
Net shares
+150K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | A · Award | +150K | — | — | 219.1% | 68.46K | 218.46K |
| Total | +150K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported